Search clinical trials for: Budesonide in Calfactant

Total 9487 results

AstraZeneca

Completed

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg (CHASE 3)

Asthma

United States, Mexico, Slovakia, Panama
Hospital General de Requena
Esteve

Completed

Efficacy of Budesonide-Formoterol in Bronchiectasis

Bronchiectasis

Spain
Kecioren Education and Training Hospital

Completed

Budesonide for Emergency Treatment of Acute Wheezing in Children

Asthma | Acute Asthma

Turkey
Istituto per la Ricerca e l'Innovazione Biomedica

Completed

Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis

Allergic Rhinitis

Italy
Wake Forest University

Completed

Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis

Atopic Dermatitis

United States
AstraZeneca

Completed

Titratable Dosing in Moderate to Severe Asthmatics

Asthma
University of Calgary
Ferring Pharmaceuticals

Not yet recruiting

Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis

Microscopic Colitis
NeoStrata Company, Inc.
Massachusetts General Hospital

Unknown

Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
Bausch Health Americas, Inc.
Cosmo Technologies Ltd

Completed

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

Russian Federation, United Kingdom, Latvia, Poland, Estonia, Belgium, Australia, Lithuania, France, Sweden, Israel, Italy, Romania, Slovakia, Ukraine
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

A Study of 2 Doses of MAP0010 in Adult Asthmatics (P202)

Asthma

United States
Dr. Falk Pharma GmbH

Completed

Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis

Proctitis

Germany
Medical University of Lodz

Unknown

Effect of Montelukast in Asthma in Children

Bronchial Asthma

Poland
AstraZeneca

Completed

A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.

Asthma

United States
Kyowa Kirin Co., Ltd.

Completed

A Phase 4 Clinical Study of Brodalumab

Psoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic Erythroderma

Japan
Ataturk University

Completed

Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations

Chronic Obstructive Pulmonary Disease

Turkey
Vanderbilt University Medical Center

Recruiting

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

Intubation Complication

United States
Bausch Health Americas, Inc.

Completed

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

Ulcerative Colitis

United States, Bulgaria, Canada, Czechia, Estonia, Hungary, Latvia, Lithuania, Poland, Russian Federation, Ukraine
EMS

Recruiting

Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma

Asthma

Brazil
EMS

Recruiting

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

Asthma

Brazil
Kindeva Drug Delivery

Completed

Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients

Asthma

United States
Gelb, Arthur F., M.D.

Recruiting

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Asthma

United States
Ache Laboratorios Farmaceuticos S.A.

Completed

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma (Ach-ALN)

Asthma
Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (BF-BLOCK) (BF-BLOCK)

Asthma

Finland
Intech Biopharm Ltd.
Peking University People's Hospital; Beijing Friendship Hospital; The Second... and other collaborators

Completed

Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients

Asthma

China
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Medical University of Lodz

Completed

Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma

Asthma

Poland
Sara Varea

Completed

Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

Coronavirus Infection

Spain, Argentina
University of Michigan
American Rhinologic Society

Completed

Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis

Chronic Sinusitis | Polyposis

United States
AstraZeneca

Completed

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo (CHASE 1)

Asthma

United States, Bulgaria, Hungary, Latvia, Poland, Slovakia, South Africa
Dr. Falk Pharma GmbH

Completed

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

Crohn´s Disease

Germany
Brian J Lipworth

Completed

Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD) (FARD12)

COPD

United Kingdom
Dr. Falk Pharma GmbH

Completed

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis (EOS-2)

Eosinophilic Esophagitis

Germany
Ferring Pharmaceuticals

Completed

To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis

Colitis, Ulcerative

Japan
Laval University
AstraZeneca

Completed

Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects (D5890L00013)

Asthma

Canada
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

Asthma

United States
AstraZeneca

Completed

Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma (Spacer)

Asthma

Russian Federation, Hungary, Poland
University of Utah

Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)

Multiple Myeloma

United States
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Enfermedades Respiratorias

Recruiting

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Radiation Pneumonitis

Mexico
Shire

Completed

Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis

Eosinophilic Esophagitis (EoE)

United States
Imperial College London
Royal Brompton & Harefield NHS Foundation Trust

Withdrawn

Inhaled Corticosteroids on Airway Smooth Muscle in Asthma

Asthma

United Kingdom
Sun Yat-sen University
JIANGSU JIBEIER PHARMACEUTICAL CO.,LTD

Not yet recruiting

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Nasopharyngeal Carcinoma | Chemotherapy | Myelosuppression | Leucogen

China
Bausch Health Americas, Inc.

Completed

(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

United States, Canada, India, Mexico
Pearl Therapeutics, Inc.

Completed

Pharmacokinetics and Safety Study of PT010 in Healthy Subjects

COPD

United States
Allergy and Asthma Center of El Paso
GlaxoSmithKline

Unknown

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

Asthma

United States
AstraZeneca

Completed

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

Asthma
Istituto Clinico Humanitas

Not yet recruiting

Evaluation of Efficacy, Safety and Patient' Satisfaction of Therapeutic Switch From Off-Steroids to Budesonide (Switch)

Eosinophilic Esophagitis

Italy
University of British Columbia
Johnson & Johnson Consumer Inc. (J&JCI); Genome British Columbia

Active, not recruiting

Epigenetic Health Benefits of Budesonide (Project Ace)

Environmental Exposure | Epigenetic Effects of Intranasal Steroids

Canada
Mayo Clinic

Completed

Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy

Esophageal Stricture

United States
AstraZeneca

Completed

PreAsthmaControl (PAC)

Asthma

Denmark
Eurofarma Laboratorios S.A.

Recruiting

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment (ESPIRE)

Asthma Copd

Brazil

3

Subscribe